Red Cat Holdings heads into October with 30% of its free float sold short, borrow fully exhausted, and insiders selling steadily into a stock that has lost a quarter of its value in a month.
The short positioning here is extreme by almost any measure. Short interest has climbed to 30.1% of the free float, up 13.6% over the past week and 14.8% over the past month. Every share available in the lending pool is currently borrowed: availability has sat at 0% for all but two sessions across the past six weeks, the tightest possible reading. Cost to borrow spiked to 18.2% on September 21 before pulling back to 8.2% by week's end, a cooling that coincides with short interest still rising rather than unwinding. The ORTEX short score has drifted higher each session this week, reaching 75.1 on September 29, a new high for the visible window. That score ranks in the 2nd percentile of all stocks, meaning almost every name in the market is less heavily shorted. Days to cover, using the latest FINRA fortnightly figure of 37.1 million shares, stands at 6.6 days, a meaningful friction point if sentiment were to shift.
Options traders are not leaning into the bearish side the way short sellers are. The put/call ratio is 0.36, barely above its 20-day average of 0.36, with a z-score of 0.77. The 52-week high on the PCR is only 0.53, meaning the options market has been consistently call-heavy throughout the past year. That is a striking divergence: shorts have an iron grip on every available borrow, yet options positioning remains tilted toward calls. The two data sets are pulling in opposite directions, and that contrast is worth tracking as the next earnings date on November 6 approaches.
The Street is broadly constructive but disaggregated on valuation. Evercore ISI initiated coverage at Outperform with a $15 target at end of August, while Piper Sandler took a more cautious view at Neutral with a $9 target in early September. HC Wainwright holds a $20 Buy and Needham cut its target to $15 from $20 after the August print while keeping its Buy rating. The mean target of $16.50 is more than 2.5 times the current price of $6.45, an unusually wide gap that reflects genuine disagreement rather than consensus conviction. The bull case rests on the 527% year-on-year revenue growth to $20.2 million in Q2, a $325 million cash balance after the May offering, and a defence platform with NDAA-compliant products across aerial ISR, strike, and maritime. The bear case is blunt: $20.2 million in Q2 implies the company needs roughly $115 million in H2 revenue to hit its own $150 to $180 million full-year guidance, adjusted EBITDA losses are widening, and free cash flow was negative $52.6 million last quarter. Factor scores add one firm positive note: EPS momentum ranks in the 97th and 98th percentiles over 30 and 90 days respectively, and EPS surprise ranks at the 88th percentile, meaning the company has been consistently beating expectations even as the absolute numbers remain loss-making.
The insider picture adds another layer of caution. The CEO and Chairman, Jeffrey Thompson, sold 150,000 shares on September 15 at $7.74 under a pre-arranged 10b5-1 plan, having sold the same quantity in August at $10.45 and in July at $8.51. Planned sales under 10b5-1 programmes carry less informational weight than discretionary transactions, but the cadence is consistent and the price has fallen with each tranche. Two directors, Nicholas Liuzza and Christopher Moe, sold in August without a 10b5-1 plan, which is a stronger signal. Net insider selling over the past 90 days amounts to 590,000 shares worth roughly $5.4 million. Institutional holders on the other side include State Street at 8.2% and BlackRock at 7.3%, both of which have been adding, and Hood River Capital, a growth-focused manager, filed a fresh 13G in August disclosing a 7.2% stake built from scratch. Wikipedia attention for the company is running at a z-score of 3.0 against its own 90-day history, pointing to a spike in retail interest in the week of September 23, which may explain some of the options call-skew.
Close peers are having a rough week alongside RCAT. KTOS fell 8.3% on the week and AVAV dropped 8.3%, suggesting the pressure is partly sector-wide rather than stock-specific. SWMR was the week's worst performer in the peer group, down 27.7%. The one outlier was DPRO, up 12.9% on the week, though it trades on a different exchange and with a different profile.
The next scheduled catalyst is the November 6 earnings print. With 30% of float short, zero borrow availability, and a company that needs to roughly triple its Q2 revenue run-rate to meet its own guidance, that release will test whether the bull case on execution has any traction.
See the live data behind this article on ORTEX.
Open RCAT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
